Sökning: onr:"swepub:oai:DiVA.org:uu-381806" >
Epigenomic re-confi...
Epigenomic re-configuration of primary multiple myeloma underlies the synergistic effect of combined DNMT and EZH2 inhibition.
-
Atienza-Párraga, Alba (författare)
-
Diamanti, Klev (författare)
-
Nylund, Patrick (författare)
-
visa fler...
-
Skaftason, Aron (författare)
-
Ma, Anqi (författare)
-
Jin, Jian (författare)
-
Martín-Subero, José Ignacio (författare)
-
Öberg, Fredrik (författare)
-
Komorowski, Jan (författare)
-
Jernberg-Wiklund, Helena (författare)
-
Kalushkova, Antonia (författare)
-
visa färre...
- Engelska.
- Relaterad länk:
-
https://urn.kb.se/re...
Abstract
Ämnesord
Stäng
- Multiple myeloma (MM) is characterized by an overexpression of EZH2 and a subsequent increase in H3K27me3-mediated silencing. However, the genome-wide redistribution of this mark in context with other epigenetic tags remains largely unexplored. Here, we show that EZH2 physically interacts with DNMT1 and that combined inhibition leads to a reduced G2/M arrest and increased apoptosis in MM. In addition, we present a catalogue of the genomic regulatory regions in normal plasma cells (NPC) as defined by their individual combination of histone marks. We used ChIP-seq and ATAC-seq data to generate whole-genome NPC chromatin annotations which we further analysed using DNA methylation arrays and RNA-seq. Comparison between NPC and MM demonstrated that, despite the global hypomethylation, enhancers show a tendency towards a higher DNA methylation levels in MM, whereas Polycomb and heterochromatic sites, highly methylated in NPC, show intermediate levels of the mark. Across all examined regulatory regions, 5-azacytidine treatment strongly reduced DNA methylation in MM. Furthermore, we find an extensive re-structuration of the global histone patterns in MM. We noticed a widespread increase in H3K27me3 except at active TSSs/promoters and enhancers, where we found a selective gain of the mark, suggestive of a directed silencing. In contrast, poised TSSs lose H3K27me3 and gain the activation mark H3K27ac, reflecting potential activation. Taken together, we present a comprehensive map of the epigenomic changes in MM as compared to NPC and provide insights into the interplay between EZH2 and DNMT1 in MM.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Multiple myeloma
- DNA methylation
- H3K27me3
- 5-azacytidine
- UNC1999.
Publikations- och innehållstyp
- vet (ämneskategori)
- ovr (ämneskategori)
- Av författaren/redakt...
-
Atienza-Párraga, ...
-
Diamanti, Klev
-
Nylund, Patrick
-
Skaftason, Aron
-
Ma, Anqi
-
Jin, Jian
-
visa fler...
-
Martín-Subero, J ...
-
Öberg, Fredrik
-
Komorowski, Jan
-
Jernberg-Wiklund ...
-
Kalushkova, Anto ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Av lärosätet
-
Uppsala universitet